3/28
05:27 pm
cnsp
Form PRE 14A CNS Pharmaceuticals, For: Apr 30
Neutral
Report
Form PRE 14A CNS Pharmaceuticals, For: Apr 30
2/27
05:16 pm
cnsp
Form 8-K CNS Pharmaceuticals, For: Feb 21
Medium
Report
Form 8-K CNS Pharmaceuticals, For: Feb 21
2/21
05:03 pm
cnsp
Form 8-K CNS Pharmaceuticals, For: Feb 14
Medium
Report
Form 8-K CNS Pharmaceuticals, For: Feb 14
2/14
02:25 pm
cnsp
Form SC 13G/A CNS Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G/A CNS Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
2/6
10:28 am
cnsp
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Mahery Amy
Low
Report
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Mahery Amy
2/6
10:28 am
cnsp
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Climaco John M
Low
Report
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Climaco John M
2/6
10:28 am
cnsp
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Downs Christopher
Low
Report
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Downs Christopher
2/6
10:28 am
cnsp
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Evans Carl Anthony
Low
Report
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Evans Carl Anthony
2/6
10:28 am
cnsp
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Gumulka Jerzy
Low
Report
Form 4 CNS Pharmaceuticals, For: Feb 01 Filed by: Gumulka Jerzy
2/6
10:27 am
cnsp
Form 3 CNS Pharmaceuticals, For: Feb 01 Filed by: Mahery Amy
Medium
Report
Form 3 CNS Pharmaceuticals, For: Feb 01 Filed by: Mahery Amy
2/2
05:00 pm
cnsp
Form 8-K CNS Pharmaceuticals, For: Jan 29
Low
Report
Form 8-K CNS Pharmaceuticals, For: Jan 29
1/31
04:27 pm
cnsp
Form 424B4 CNS Pharmaceuticals,
Low
Report
Form 424B4 CNS Pharmaceuticals,
1/30
06:02 am
cnsp
Form EFFECT CNS Pharmaceuticals,
Low
Report
Form EFFECT CNS Pharmaceuticals,
1/23
04:01 pm
cnsp
Form 8-K CNS Pharmaceuticals, For: Jan 17
Low
Report
Form 8-K CNS Pharmaceuticals, For: Jan 17
1/22
06:03 am
cnsp
Form S-1/A CNS Pharmaceuticals,
High
Report
Form S-1/A CNS Pharmaceuticals,
1/10
05:27 pm
cnsp
Form S-1/A CNS Pharmaceuticals,
High
Report
Form S-1/A CNS Pharmaceuticals,